{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:53:30Z","timestamp":1761562410058,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.carrev.2017.05.011","type":"journal-article","created":{"date-parts":[[2017,5,13]],"date-time":"2017-05-13T02:30:41Z","timestamp":1494642641000},"page":"50-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["Left ventricular perforation in a patient with a left ventricular aneurysm during NOGA\u00ae catheter mapping"],"prefix":"10.1016","volume":"19","author":[{"given":"Gaurav K.","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5217-6348","authenticated-orcid":false,"given":"Marie-France","family":"Poulin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Schaer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2017.05.011_bb0005","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ahj.2011.01.028","article-title":"A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF)","volume":"161","author":"Perin","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2017.05.011_bb0010","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ahj.2011.11.020","article-title":"Randomized, double-blind pilot study of transendocardial injection of autologous aldehyde dehydrogenase-bright stem cells in patients with ischemic heart failure","volume":"163","author":"Perin","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.carrev.2017.05.011_bb0015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCRESAHA.115.306332","article-title":"A phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure","volume":"117","author":"Perin","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2017.05.011_bb0020","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2017.05.011_bb0025","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.3727\/096368916X692087","article-title":"Clinical benefits of stem cells for chronic symptomatic systolic heart failure: a systematic review of the existing data and ongoing trials","volume":"25","author":"Poulin","year":"2016","journal-title":"Cell Transplant"},{"key":"10.1016\/j.carrev.2017.05.011_bb0030","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The RENEW trial: efficacy and safety of intramyocardial autologous CD34(+) cell administration in patients with refractory angina","volume":"9","author":"Povsic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2017.05.011_bb0035","doi-asserted-by":"crossref","first-page":"B333","DOI":"10.1016\/j.jacc.2016.09.852","article-title":"TCT-824 reduction in ventricular arrhythmias with Ixmyelocel-T: results from the IxCell-DCM trial","volume":"68","author":"Henry","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2017.05.011_bb0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3727\/096368916X692933","article-title":"ALLogeneic Heart STem Cells to Achieve Myocardial Regeneration (ALLSTAR) trial: rationale and design","volume":"26","author":"Chakravarty","year":"2017","journal-title":"Cell Transplant"},{"key":"10.1016\/j.carrev.2017.05.011_bb0045","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ejhf.676","article-title":"An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial","volume":"19","author":"Choudhury","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.carrev.2017.05.011_bb0050","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/CIRCRESAHA.111.245993","article-title":"Intramyocardial, autologous CD34+ cell therapy for refractory angina","volume":"109","author":"Losordo","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.carrev.2017.05.011_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0002-9149(82)90023-6","article-title":"Prognostic significance of angiographically documented left ventricular aneurysm from the Coronary Artery Surgery Study (CASS)","volume":"50","author":"Faxon","year":"1982","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.carrev.2017.05.011_bb0060","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0735-1097(02)02118-6","article-title":"Electromechanical mapping for determination of myocardial contractility and viability. A comparison with echocardiography, myocardial single-photon emission computed tomography, and positron emission tomography","volume":"40","author":"Keck","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2017.05.011_bb0065","first-page":"393","article-title":"Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease","author":"Gyongyosi","year":"2011"},{"issue":"18","key":"10.1016\/j.carrev.2017.05.011_bb0070","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1161\/01.CIR.0000070596.30552.8B","article-title":"Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure","volume":"107","author":"Perin","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.carrev.2017.05.011_bb0075","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jacc.2004.12.068","article-title":"Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject One trial","volume":"45","author":"Kastrup","year":"2005","journal-title":"J Am Coll Cardiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838917301744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838917301744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:14:48Z","timestamp":1761560088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838917301744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1553838917301744"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2017.05.011","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left ventricular perforation in a patient with a left ventricular aneurysm during NOGA\u00ae catheter mapping","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2017.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}